+499.5%
MRNA vs MET
+24.0%
+475.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MET | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -2.7% |
| 7D | +5.5% | +1.2% | +4.3% | +6.0% |
| 30D | +158.7% | +1.4% | +157.3% | +159.1% |
| 3M | +182.1% | +17.7% | +164.4% | +168.4% |
| 6M | +151.8% | +35.0% | +116.8% | +124.2% |
| YTD | +393.6% | +26.3% | +367.3% | +345.2% |
| 1Y | +499.5% | +22.8% | +476.6% | +433.5% |
| All | +499.5% | +24.0% | +475.5% | +433.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MET.
Daily Out/Under-Performance
Portfolio return minus MET return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MET return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MET wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling